Quantification and Characterization of Subvisible Proteinaceous Particles in Opalescent mAb Formulations Using Micro-Flow Imaging
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 99 (6) , 2628-2642
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Understanding and Modulating Opalescence and Viscosity in a Monoclonal Antibody FormulationJournal of Pharmaceutical Sciences, 2010
- Quantitation of protein particles in parenteral solutions using micro-flow imagingJournal of Pharmaceutical Sciences, 2009
- Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product QualityJournal of Pharmaceutical Sciences, 2009
- IgG particle formation during filling pump operation: A case study of heterogeneous nucleation on stainless steel nanoparticlesJournal of Pharmaceutical Sciences, 2009
- The Complex Inter-Relationships Between Protein Flexibility and StabilityJournal of Pharmaceutical Sciences, 2008
- Stabilization of a hydrophobic recombinant cytokine by human serum albuminJournal of Pharmaceutical Sciences, 2007
- A simple method for the detection of insoluble aggregates in protein formulationsJournal of Pharmaceutical Sciences, 2007
- Detection and characterization of protein aggregates by fluorescence microscopyInternational Journal of Pharmaceutics, 2007
- Induction and analysis of aggregates in a liquid IgG1-antibody formulationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Challenges in the development of high protein concentration formulationsJournal of Pharmaceutical Sciences, 2004